Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

These characteristics were associated with various biological processes, such as immune response, autophagy, iron death, dryness, epithelio‐mesenchymal transformation, copper death, hypoxia, glycolysis, lipogenesis, vitamin D, epigenetics, N6‐methyladenosine, aging, WNT and drug sensitivity.

Source: Comparison of the Prognostic Models From Other Studies. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In addition, we performed gene colocalisation analysis and Mendelian randomisation analysis.

Source: Abstract.

After normalisation and scaling, the batch effect between patients was then removed using the harmony algorithm in Seurat.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Autophagy Associated Genes (ARGs) ‐Based Predictive Model AIDPS for Prostate Cancer

Genetic instrumental-variable study · Journal of Cellular and Molecular Medicine · 2025

Original publication title

Autophagy Associated Genes (ARGs) ‐Based Predictive Model AIDPS for Prostate Cancer

Zhiyi Zhao; Yongjin Yang; Zhou Sun; LianMing Fan; Lingyun Liu

© 2025 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

ABSTRACT

Prostate cancer (PCa) is one of the most common cancers in men worldwide. Autophagy‐related genes (ARGs) may play an important role in various biological processes of PCa. The aim of this study was to identify and evaluate autophagy‐related features to predict clinical outcomes in patients with PCa. Single‐cell sequencing data and RNA sequencing data was included from public GEO and TCGA databases. Cells were clustered and annotated by dimension reduction cluster analysis. Epithelial cells, T cells and fibroblasts were isolated to explore their heterogeneity.

Autophagy‐related genes were obtained from the HADb database. Survival analysis was conducted by K: M curve, and prognostic risk model was established using 101 machine learning algorithms. In addition, we performed gene colocalisation analysis and Mendelian randomisation analysis. Univariate Cox analysis was used to screen out prognostic genes from DEGs and ARGs in each dataset. Risk model was generated by artificial intelligence‐derived prognostic signature (AIDPS), which showed better prognostic performance in every dataset than other published models for PCa. The disease‐free period (DFS) of patients in the high‐risk group was significantly worse than that in the low‐risk group (all p < 0.05).

The best model is the Ridge (C‐index 0.726). We found significant differences in IC50 values of the Dactinomycin_1811, Dactolisib_1057, Luminespib_1559 and Paclitaxel_1080 between groups. In SNP sites rs2743987 and rs7768988, there was a significant correlation between prostate hyperplasia and prostate cancer. Our ARG‐based predictive model AIDPS is a reliable and effective tool for prognosis and treatment of prostate cancer.

Authors’ abstract

ABSTRACT

Prostate cancer (PCa) is one of the most common cancers in men worldwide. Autophagy‐related genes (ARGs) may play an important role in various biological processes of PCa. The aim of this study was to identify and evaluate autophagy‐related features to predict clinical outcomes in patients with PCa. Single‐cell sequencing data and RNA sequencing data was included from public GEO and TCGA databases. Cells were clustered and annotated by dimension reduction cluster analysis. Epithelial cells, T cells and fibroblasts were isolated to explore their heterogeneity.

Autophagy‐related genes were obtained from the HADb database. Survival analysis was conducted by K: M curve, and prognostic risk model was established using 101 machine learning algorithms. In addition, we performed gene colocalisation analysis and Mendelian randomisation analysis. Univariate Cox analysis was used to screen out prognostic genes from DEGs and ARGs in each dataset. Risk model was generated by artificial intelligence‐derived prognostic signature (AIDPS), which showed better prognostic performance in every dataset than other published models for PCa. The disease‐free period (DFS) of patients in the high‐risk group was significantly worse than that in the low‐risk group (all p < 0.05).

The best model is the Ridge (C‐index 0.726). We found significant differences in IC50 values of the Dactinomycin_1811, Dactolisib_1057, Luminespib_1559 and Paclitaxel_1080 between groups. In SNP sites rs2743987 and rs7768988, there was a significant correlation between prostate hyperplasia and prostate cancer. Our ARG‐based predictive model AIDPS is a reliable and effective tool for prognosis and treatment of prostate cancer.

Publication and source details

Original title: Autophagy Associated Genes (ARGs) ‐Based Predictive Model AIDPS for Prostate Cancer

Zhiyi Zhao; Yongjin Yang; Zhou Sun; LianMing Fan; Lingyun Liu

Journal of Cellular and Molecular Medicine · 2025

* Correspondence:
Lingyun Liu (tmxlly@jlu.edu.cn)
LianMing Fan (zxyyflm@163.com)
© 2025 The Author(s). Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd.https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:37:24.861653+00:00

DOI: 10.1111/jcmm.70213 · PMC11717666